HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG MEDICARE BENEFICIARIES INITIATING VENETOCLAX VS. BTKIS FOR RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: A REAL-WORLD STUDY

被引：0
|
作者：
Huntington, S. [1 ]
Manzoor, B. S. [2 ]
Jawaid, D. [2 ]
Puckett, J. [3 ]
Alhasani, H. [2 ]
Ravelo, A. [4 ]
Kamal-Bahl, S. [5 ]
Emechebe, N. [2 ]
Doshi, J. A. [6 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] AbbVie Inc, Chicago, IL USA
[3] COVIA Hlth Solut, Philadelphia, PA USA
[4] Genentech Inc, San Francisco, CA USA
[5] COVIA Hlth Solut, Lansdale, PA USA
[6] Univ Penn, Philadelphia, PA USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE158
引用
收藏
页码：S88 / S89
页数：2
相关论文
共 50 条
  • [1] Real-world adherence and discontinuation among Medicare beneficiaries initiating venetoclax vs. BTKis in relapsed/refractory chronic lymphocytic leukemia
    Huntington, Scott F.
    Manzoor, Beenish S.
    Puckett, Justin T.
    Kamal-Bahl, Sachin
    Alhasani, Hasan
    Ravelo, Arliene
    Jawaid, Dureshahwar
    Doshi, Jalpa A.
    LEUKEMIA & LYMPHOMA, 2023, 64 (14) : 2316 - 2323
  • [2] Adherence and Discontinuation Among Medicare Beneficiaries Initiating Venetoclax versus BTKis for Relapsed/Refractory Chronic Lymphocytic Leukemia
    Huntington, Scott F.
    Manzoor, Beenish S.
    Puckett, Justin T.
    Kamal-Bahl, Sachin
    Alhasani, Hasan
    Ravelo, Arliene
    Fuldeore, Mahesh
    Doshi, Jalpa A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S277 - S278
  • [3] Real-World Comparison of Healthcare Costs of Venetoclax-Obinutuzumab Vs. Btki Use Among Elderly US Medicare Beneficiaries with Chronic Lymphocytic Leukemia in the Front-Line (1L) Setting
    Manzoor, Beenish S.
    Huntington, Scott F.
    Jawaid, Dureshahwar
    Puckett, Justin T.
    Emechebe, Nnadozie
    Ravelo, Arliene
    Kamal-Bahl, Sachin
    Doshi, Jalpa A.
    BLOOD, 2023, 142
  • [4] Costs and health care resource utilization among Medicare beneficiaries diagnosed with chronic lymphocytic leukemia
    Lee, Tsung-Ying
    Johnson, Abree
    Cooke, Catherine E.
    Yared, Jean A.
    Summers, Amanda
    Yang, Keri
    Liu, Sizhu
    Tang, Boxiong
    Onukwugha, Eberechukwu
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (05): : 430 - 440
  • [5] Real-world healthcare resource utilization (HRU)/costs associated with venetoclax treatment among chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) patients.
    Rogers, Kerry Anne
    Emond, Bruno
    Manceur, Ameur M.
    Kinkead, Frederic
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Healthcare Resource Utilization (HRU) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
    Kozma, Chris
    Slaton, Terra
    McKenzie, Scott
    Ellis, Lone
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S132 - S132
  • [7] Healthcare Resource Utilization and Costs of Relapsed or Refractory Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Treated with Ibrutinib
    Yang, Xiaoqin
    Zanardo, Enrico
    Lejeune, Dominique
    De Nigris, Enrico
    Sarpong, Eric
    Farooqui, Mohammed Z. H.
    Laliberte, Francois
    BLOOD, 2022, 140 : 10911 - 10912
  • [8] Healthcare resource utilization and costs associated with first-line ibrutinib compared to chemoimmunotherapy treatment among Medicare beneficiaries with chronic lymphocytic leukemia
    Huang, Qing
    Emond, Bruno
    Lafeuille, Marie-Helene
    Gupta, Deepshekhar
    Lefebvre, Patrick
    Sundaram, Murali
    Mato, Anthony
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (12) : 2009 - 2018
  • [9] Examining the medical resource utilization and costs of relapsed and refractory chronic lymphocytic leukemia in Ontario
    Hassan, S.
    Seung, S. J.
    Cheung, M. C.
    Fraser, G.
    Kuriakose, B.
    Trambitas, C.
    Mittmann, N.
    CURRENT ONCOLOGY, 2017, 24 (01) : E50 - E54
  • [10] Real-world comparison of health care costs of venetoclax-obinutuzumab vs Bruton's tyrosine kinase inhibitor use among US Medicare beneficiaries with chronic lymphocytic leukemia in the frontline setting
    Huntington, Scott F.
    Manzoor, Beenish S.
    Jawaid, Dureshahwar
    Puckett, Justin T.
    Emechebe, Nnadozie
    Ravelo, Arliene
    Kamal-Bahl, Sachin
    Doshi, Jalpa A.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (10): : 1106 - 1116
12345